ConverSant R&D (Private limited company)

ConverSant
BE 0805.558.967 Active ●Elenestraat 153, 9620 Zottegem

ConverSant R&D is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0805.558.967. It was founded on 07-09-2023. Its registered office is in Zottegem. Its main activity is: Office administrative, office support and other business support activities. Its annual accounts for 2025 report equity of € 115 574 and a profit of € 6 622. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0805.558.967
VAT registered
Yes
Founded
07-09-2023
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Elenestraat 153, 9620 Zottegem
Main activity
Office administrative, office support and other business support activities
NACE activities
82990 Autres activités de service de soutien aux entreprises nca
70200 Activités de conseil pour les affaires et autre conseil de gestion
73300 Activités de conseil en relations publiques et communication
82100 Activités de service de bureau et de soutien administratif

Key figures of ConverSant R&D

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 6 622-93 %€ 93 099+758 %€ 10 853
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 115 574+6 %€ 108 952+587 %€ 15 853
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 131 724-12 %€ 149 633+467 %€ 26 378
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 16 533-87 %€ 126 677+731 %€ 15 248
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
---

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Zottegem.

CompanyTown
DATAFISK 9620 Zottegem
MPTS 9620 Zottegem
Grotenberge 9620 Zottegem
D.R.A.-CONSULT 9620 Zottegem
QUADRATUM 9620 Zottegem
BAKA 9620 Zottegem
Saturna Corporates 9620 Zottegem
AUTOMATEN SERVICE VOLCKAERT 9620 Zottegem
Looking for more information about ConverSant R&D?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is ConverSant R&D still active? Yes. The Crossroads Bank for Enterprises lists ConverSant R&D as active.

What is the VAT number of ConverSant R&D? The VAT number of ConverSant R&D is BE 0805.558.967.

When was ConverSant R&D founded? ConverSant R&D was founded on 07-09-2023.

What is the address of ConverSant R&D? The current registered office of ConverSant R&D is Elenestraat 153, 9620 Zottegem.

When did ConverSant R&D last file annual accounts? The latest annual accounts of ConverSant R&D were filed on 28-07-2026.

Does ConverSant R&D file its annual accounts on time? Yes. ConverSant R&D filed its annual accounts within the legal deadline for each of its last 3 financial years.

Is ConverSant R&D financially healthy? Addrly gives ConverSant R&D a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is ConverSant R&D profitable? The annual accounts of ConverSant R&D for 2025 show a profit of € 6 622.

What is the equity of ConverSant R&D? The equity of ConverSant R&D was € 115 574 at the close of the 2025 financial year.

Who are the directors of ConverSant R&D? The annual accounts of ConverSant R&D record 1 mandate. The name, role and dates are visible with a free account.

Can ConverSant R&D receive Peppol e-invoices? Yes. ConverSant R&D is registered on the Peppol network and can receive structured electronic invoices.

What does ConverSant R&D do? The main activity of ConverSant R&D is: Office administrative, office support and other business support activities.

Sources

How Addrly builds and refreshes this data